确定RNA结合蛋白YBX3作为清细胞脏细胞癌中的瘤基因
Chen Wang1, Zhijie You2, Yihui He1
1Department of Pathology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, 350001, Fujian, China.
Y盒结合蛋白3 (YBX3) 影响清细胞细胞癌 (ccRCC) 的进展和免疫透. 高YBX3表达与晚期ccRCC和较差的存活率相关,这表明它是一种潜在的预后生物标志物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- Y盒结合蛋白3 (YBX3) 对于细胞过程至关重要,并与各种癌症有关.
- 了解YBX3在清细胞细胞癌 (ccRCC) 中的作用对于治疗的发展至关重要.
研究的目的:
- 研究YBX3在ccRCC预后,免疫透和进展中的作用.
- 评估YBX3作为ccRCC的潜在诊断和预后生物标志物.
主要方法:
- 使用癌症基因组图谱 (TCGA) 分析了ccRCC组织中的YBX3表达.
- 利用后勤回归,多变量考克斯和卡普兰梅尔分析来预后相关性.
- 使用TIMER 2.0进行免疫细胞透分析和体外试验 (siYBX3,oeYBX3) 来评估ccRCC进展.
主要成果:
- 高YBX3表达与ccRCC中晚期瘤阶段,等级和TNM阶段有关.
- YBX3的丰度与特定的免疫细胞透 (aDC,pDC,Th1,Treg) 相对应.
- 较高的YBX3表达与特定ccRCC亚组 (M0,N0,T2) 的总生存率降低有关.
结论:
- Y盒结合蛋白3 (YBX3) 显著影响ccRCC进展和患者预后.
- YBX3可以作为一个有价值的预后生物标志物和ccRCC的潜在治疗点.
更多相关视频
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
相关概念视频
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
